Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Dec 5, 2025, 4:00 PM EST
1.651
-0.019 (-1.15%)
After-hours: Dec 5, 2025, 6:19 PM EST
Protagenic Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3 | 4 | 4 | 7 | 23 | 11 | |
| Market Cap Growth | - | -20.28% | -36.49% | -70.56% | 115.87% | -24.82% | |
| Enterprise Value | 5 | 2 | -0 | -1 | 13 | 11 | |
| Last Close Price | 1.67 | 6.86 | 13.86 | 22.40 | 77.56 | 58.80 | |
| PB Ratio | - | 3.46 | 1.20 | 1.00 | 2.36 | -9.46 | |
| P/TBV Ratio | - | 3.46 | 1.20 | 1.00 | 2.36 | - | |
| Debt / Equity Ratio | - | - | - | 0.05 | 0.03 | -1.19 | |
| Quick Ratio | 0.81 | 1.95 | 6.19 | 7.13 | 12.97 | 1.02 | |
| Current Ratio | 0.86 | 2.00 | 6.41 | 7.18 | 13.83 | 1.34 | |
| Return on Equity (ROE) | -512.79% | -236.06% | -94.48% | -42.18% | -102.89% | - | |
| Return on Assets (ROA) | -189.60% | -113.49% | -45.78% | -23.29% | -43.35% | -185.27% | |
| Return on Capital (ROIC) | -330.87% | -152.23% | -51.77% | -25.38% | -49.36% | - | |
| Earnings Yield | - | -157.86% | -113.89% | -51.42% | -19.26% | -23.43% | |
| FCF Yield | -112.20% | -120.46% | -87.77% | -28.86% | -11.92% | -12.40% | |
| Buyback Yield / Dilution | -28.54% | -12.78% | -0.62% | -17.17% | -42.57% | -0.76% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.